HLN
p390.90
▲+1.30%
Stock
Haleon plc ORD GBP0.01
Official Company Name: Haleon plc
Stock Symbol: HLN
Stock Market: London Stock Exchange - LSE
Currency: Penny sterling - GBX
HLN - Stock Indices
HLN Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▲+20.56%
Daily closing prices, with moving averages and volumes - Penny sterling (GBX)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
United Kingdom
Company Description
Haleon plc, headquartered in Brentford, UK, specializes in the R&D, manufacture, and sale of consumer healthcare products across various regions. Their offerings encompass therapeutic oral health, pain relief, respiratory, digestive products, and vitamins and supplements. Key brands include Panadol, Voltaren, Advil, Sensodyne, and Centrum.
HLN Stock Data
| Open | p383.90 |
| High | p391.60 |
| Low | p383.00 |
| Close | p390.90 |
| Volume | 18,903,033 |
| Previous Close | p385.90 |
| 1-Day Change | 5.00 |
| 1-Year Change | 66.65 |
| Average Daily Volume | 22,596,980 |
| 52-Week High | p397.00 |
| 52-Week Low | p313.95 |
Ratios as of Jan. 25, 2025
| Beta | 0.24 |
| Trailing PE | 28.58 |
| Forward PE | 0.19 |
Unlock Financial AI: get advanced tools and data with a free trial of Disfold AI
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.